Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Enrico Cerrato and Fabrizio D'Ascenzo.
Enrico Cerrato
Connection Strength
3.375
Fabrizio D'Ascenzo
  1. Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). Int J Cardiol. 2019 09 01; 290:64-69.
    View in: PubMed
    Score: 0.204
  2. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
    View in: PubMed
    Score: 0.203
  3. Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies. Int J Cardiol. 2018 Nov 15; 271:42-48.
    View in: PubMed
    Score: 0.199
  4. Radial and femoral access for interventional fellows performing diagnostic coronary angiographies: the LEARN-Cardiogroup II, a prospective multicenter study. J Cardiovasc Med (Hagerstown). 2018 Nov; 19(11):650-654.
    View in: PubMed
    Score: 0.198
  5. Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):536-542.
    View in: PubMed
    Score: 0.197
  6. Reply to: Cardiac protection by remote ischemic preconditioning in patients with diabetes status. Int J Cardiol. 2018 09 15; 267:56.
    View in: PubMed
    Score: 0.196
  7. Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. Int J Cardiol. 2018 Dec 15; 273:29-33.
    View in: PubMed
    Score: 0.196
  8. Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):283-288.
    View in: PubMed
    Score: 0.192
  9. The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial. Int J Cardiol. 2018 04 15; 257:1-6.
    View in: PubMed
    Score: 0.191
  10. What is the optimal treatment for symptomatic patients with isolated coronary myocardial bridge? A systematic review and pooled analysis. J Cardiovasc Med (Hagerstown). 2017 Oct; 18(10):758-770.
    View in: PubMed
    Score: 0.184
  11. Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis. Int J Cardiol. 2017 Oct 01; 244:54-58.
    View in: PubMed
    Score: 0.180
  12. Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). Am J Cardiol. 2017 Apr 01; 119(7):978-982.
    View in: PubMed
    Score: 0.175
  13. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). Eur J Clin Invest. 2021 Nov; 51(11):e13582.
    View in: PubMed
    Score: 0.060
  14. [Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]. Rev Esp Cardiol. 2021 Jul; 74(7):608-615.
    View in: PubMed
    Score: 0.058
  15. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry. Rev Esp Cardiol (Engl Ed). 2021 Jul; 74(7):608-615.
    View in: PubMed
    Score: 0.058
  16. Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021; 28(2):202-214.
    View in: PubMed
    Score: 0.057
  17. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. Front Endocrinol (Lausanne). 2020; 11:599255.
    View in: PubMed
    Score: 0.057
  18. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966.
    View in: PubMed
    Score: 0.057
  19. Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design. Contemp Clin Trials Commun. 2020 Dec; 20:100654.
    View in: PubMed
    Score: 0.057
  20. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 08; 33(4):737-745.
    View in: PubMed
    Score: 0.056
  21. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):276-281.
    View in: PubMed
    Score: 0.049
  22. State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. J Invasive Cardiol. 2018 08; 30(8):301-309.
    View in: PubMed
    Score: 0.049
  23. Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):215-223.
    View in: PubMed
    Score: 0.049
  24. Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]. Int J Cardiol. 2018 07 15; 263:188.
    View in: PubMed
    Score: 0.049
  25. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Rev Esp Cardiol (Engl Ed). 2019 Apr; 72(4):298-304.
    View in: PubMed
    Score: 0.048
  26. Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 01; 270:107-112.
    View in: PubMed
    Score: 0.048
  27. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018 07; 167:142-148.
    View in: PubMed
    Score: 0.048
  28. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. JACC Cardiovasc Interv. 2017 12 11; 10(23):2401-2410.
    View in: PubMed
    Score: 0.047
  29. Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. Int J Cardiol. 2018 Jan 01; 250:80-85.
    View in: PubMed
    Score: 0.046
  30. Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. Am J Cardiol. 2017 07 01; 120(1):33-39.
    View in: PubMed
    Score: 0.044
  31. Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection. Int J Cardiol. 2017 Jul 01; 238:105-109.
    View in: PubMed
    Score: 0.044
  32. Outcome of coronary lesions with deferred revascularization due to negative fractional flow reserve in subjects with acute coronary syndrome. Int J Cardiol. 2017 Mar 01; 230:335-338.
    View in: PubMed
    Score: 0.044
  33. Transcatheter aortic valve implantation in a 54-year-old patient with aggressive HIV. World J Clin Cases. 2014 Apr 16; 2(4):97-9.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.